2024 Bluebirdbio stock - The market expects Bluebird Bio (BLUE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2022. This widely-known consensus ...

 
jess.rowlands@bluebirdbio.com. Investor Contacts. Courtney O’Leary. Investor Relations (978) 621-7347. coleary@bluebirdbio.com. stock quote stock sub menu. Stock Quote; Stock Chart (Common Stock) Exchange (US Dollar) Price: Change (%) Volume: Today's Open: Previous Close: Intraday High: Intraday Low:. Bluebirdbio stock

Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.bluebird bio (BLUE) – bluebird bio rallied 7.3% in premarket trading after the Food and Drug Administration approved the company's gene therapy for a rare and lethal brain disease in children.bluebird bio Inc (BLUE) stock is trading at $4.06 as of 1:23 PM on Friday, Dec 1, a gain of $0.23, or 6.15% from the previous closing price of $3.82. The stock has traded between $3.76 and $4.18 so far today. Volume today is less active than usual. So far 2,498,462 shares have traded compared to average volume of 4,012,219 shares.On average, Wall Street analysts predict that Bluebird Bio's share price could reach $7.55 by Nov 8, 2024. The average Bluebird Bio stock price prediction ...Nov 29, 2023 · See the latest bluebird bio Inc stock price (BLUE:XNAS), related news, valuation, dividends and more to help you make your investing decisions. bluebird bio (BLUE) – bluebird bio rallied 7.3% in premarket trading after the Food and Drug Administration approved the company's gene therapy for a rare and lethal brain disease in children.The case for buying the dip isn't exactly a slam dunk. With the stock down 52% in the last three months, Bluebird Bio ( BLUE -1.28%) shareholders are bound to be feeling pretty antsy. Between the ...Latest news about bluebird bio, Inc. Wedbush Lowers bluebird bio's Price Target to $5 From $7, Maintains Neutral Rating. Nov. 08. MT. Transcript : Bluebird bio, Inc., Q3 2023 Earnings Call, Nov 07, 2023. Nov. 07. CI. Earnings Flash (BLUE) BLUEBIRD BIO Reports Q3 Revenue $12.4M, vs. Street Est of $13.4M. Nov. 07.Bluebird bio seeks FDA priority review for sickle cell disease therapy lovo-cel Apr. 24, 2023 7:55 AM ET bluebird bio, Inc. (BLUE) VRTX , CRSP By: Dulan Lokuwithana , SA News Editor 15 Comments ...When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...The company, currently valued at $348.96M, closed the last trade at $3.37 per share which meant it gained $0.25 on the day or 8.01% during that session. The EVGO stock price is -142.14% off its 52-week high price of $8.16 and 44.21% above the 52-week low of $1.88. If we look at the company’s 10-day average daily trading volume, we find …bluebird bio, Inc. (BLUE) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.2600 +0.4400 (+11.52%) At close: 04:00PM EST 4.3300 +0.07 (+1.64%) …Get the latest bluebird bio Inc (BLUE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …The past three years have been a southbound roller coaster for Bluebird Bio (BLUE 8.43%). The small-cap biotech encountered a series of headwinds, losing 90% of its value.bluebird bio Inc. Watch NEW Set a price target alert Open Last Updated: Nov 27, 2023 1:11 p.m. EST Real time quote $ 3.7650 -0.1250 -3.21% Previous Close $3.8900 Advanced …What happened. Shares of the gene therapy pioneer Bluebird Bio ( BLUE -1.04%) have been under heavy pressure this week. The biotech's stock dropped by a noteworthy 28.8% during the first three and ...10 thg 3, 2021 ... BLUE Stock Pops On Gene Therapy Analysis ... On the stock market today, BLUE stock jumped 8.1% to 32.48. Bluebird uses an empty virus to deliver ...Nov 28, 2023 · Buy or Hold candidate since Nov 15, 2023 Gain 16.72% PDF. No changes to the price of bluebird bio stock on the last trading day (Tuesday, 28th Nov 2023). During the last trading day the stock fluctuated 5.19% from a day low at $3.66 to a day high of $3.85. The price has risen in 6 of the last 10 days and is up by 27.15% over the past 2 weeks. Dec 1, 2023 · 12 analysts have issued 1-year price objectives for bluebird bio's shares. Their BLUE share price targets range from $3.00 to $13.00. On average, they expect the company's share price to reach $7.62 in the next twelve months. This suggests a possible upside of 95.9% from the stock's current price. If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.The high in the last 52 weeks of bluebird bio stock was 8.58. According to the current price, bluebird bio is 50.47% away from the 52-week high. What are analysts …Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Trading bluebird bio to $6: Bluebird bio (BLUE) is a biotech company focused on developing and commercializing gene and cell therapies to treat genetic diseases. Lead asset LentiGlobin (Zynteglo) is approved in US and Europe for the treatment of transfusion-dependent thalassemia. Bluebird's LentiGlobin (lovo-cel) is also in prBluebird bio (BLUE ...reuters.com - October 30 at 9:21 AM. bluebird bio Enters into Advance Agreement to Sell Priority Review Voucher, if Granted, for $103 Million. finance.yahoo.com - October 30 at 9:21 AM. Bluebird stock falls 10% ahead of FDA meeting for rival sickle cell therapy. msn.com - October 27 at 6:13 PM.Bluebird stock slides as company delays sickle-cell drug. Andrew Obenshain is the CEO of bluebird bio. After its split into two companies — one focused on gene therapy, the other on cancer ...The current stock price for Safety Shot Inc (SHOT) is $5.80. The stock experienced a significant increase during the last trading session, reaching $5.20 after opening at $4.40. It dipped to a low of $4.3597 before ultimately closing at $4.85. Top 5 EV Tech Stocks to Buy for 2023. The electric vehicle boom is accelerating – and fast.bluebird bio Inc (BLUE) stock is higher by 0.26% while the S&P 500 is down -0.11% as of 11:47 AM on Thursday, Nov 30. BLUE has risen $0.01 from the previous closing price of $3.86 on volume of 1,460,801 shares. Over the past year the S&P 500 is up 14.86% while BLUE is down -49.41%. BLUE lost -$0.74 per share in the over the last 12 …Another factor that may be contributing to BLUE stock gaining ground today — which jumped 17% and is up nearly 22% at time of writing — centers on possible short-squeeze speculation. According ...12 thg 7, 2023 ... Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows. ... bluebird bio's product pipeline (www.Bluebird Bio ( BLUE) is trending after the U.S. Food and Drug Administration (FDA) lifted its hold on the company’s sickle cell disease treatment. Bluebird Bio says it’s on track to submit a ...Jul 19, 2023 · Pgiam/iStock via Getty Images. bluebird bio ( NASDAQ: BLUE) added ~8% pre-market Wednesday after Bank of America upgraded the stock to Buy from Neutral, citing a potential FDA approval for its new ... The current price bluebird bio (BLUE) is trading at is $3.87, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Popular ChannelsThe high in the last 52 weeks of bluebird bio stock was 8.58. According to the current price, bluebird bio is 50.47% away from the 52-week high. What are analysts …Nov 26, 2023 · Target values for the price of one bluebird bio share for Nov 2025. The weighted average target price per bluebird bio share in Nov 2025 is: 8.72. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.746% volatility is expected. Pessimistic target level: 7.95. Optimistic target level: 9.91. November 04, 2021 07:00 AM Eastern Daylight Time. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- bluebird bio, Inc. (NASDAQ: BLUE) today announced the company has completed the tax-free spin-off of its ...[relinking] Home Product Place Promotion Price Bluebird bio, Inc. (BLUE) reported a total revenue of $49.9 million in the third quarter of 2022. The company's net loss for the third quarter of 2022 was $116.7 million. Bluebird bio, Inc. (BLUE) had cash, cash equivalents, and marketable securities totaling $1.1 billion as of September 30, 2022. Bluebird bio, …Between 2012 and 2021, FDA approved on average 44 drugs per year, skewed upwards by the 50+ annual tally between 2018 and 2021 (Fig. 1 ). Overall, it was a golden decade, with 445 new biologics ...See the latest bluebird bio Inc stock price (BLUE:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Get the latest bluebird bio, Inc. (BLUE) stock news and headlines to help you in your trading and investing decisions.bluebird bio. bluebird bio received FDA accelerated approval for SKYSONA® (elivaldogene autotemcel) gene therapy for early, active cerebral adrenoleukodystrophy (CALD). SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys with this devastating and fatal neurodegenerative disease.As for liquidity, bluebird bio reported ~$227M in cash, cash equivalents, marketable securities, and restricted cash as of 2022 year-end and indicated a cash runway until Q4 2024, including ~$45M ...bluebird bio Stock Down 1.0 %. Shares of NASDAQ:BLUE opened at $3.82 on Friday. The firm has a market cap of $417.68 million, a P/E ratio of -5.16 and a beta of 0.87. bluebird bio, Inc. has a 12 ...bluebird bio (BLUE) Stock Gains 25.6% in a Month: Here's How. bluebird bio (BLUE) rises 25.6% in past thirty days on upbeat earnings results and promising progress with its …- Commercial launch of ZYNTEGLO® (betibeglogene autotemcel) underway; on track for first apheresis in the fourth quarter of 2022 -- Chris Krawtschuk appointed chief financial officer - - Ended quarter with $186M in cash and cash equivalents, marketable securities and restricted cash - SOMERVILLE, Mass.--(BUSINESS WIRE)--Nov. 7, 2022-- bluebird …BLUE Bluebird bio Inc Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ)12 thg 7, 2023 ... Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows. ... bluebird bio's product pipeline (www.10 thg 3, 2021 ... BLUE Stock Pops On Gene Therapy Analysis ... On the stock market today, BLUE stock jumped 8.1% to 32.48. Bluebird uses an empty virus to deliver ...Find the latest bluebird bio, Inc. (BLUE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Bluebird Bio. Market Cap. $425M. Today's Change. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s ...Shares of Bluebird Bio ( BLUE 0.61%) were sinking 10.4% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The decline came after the company ...View the latest bluebird bio Inc. (BLUE) stock price, news, historical charts, analyst ratings and financial information from WSJ. Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... bluebird bio, Inc. …With that in mind, let's look at two relatively risky small-cap stocks that could be worthwhile investments if everything goes well: bluebird bio ( BLUE 1.93%) and Planet 13 Holdings ( PLNH.F 2.13 ...Discover historical prices for BLUE stock on Yahoo Finance. View daily, weekly or monthly format back to when bluebird bio, Inc. stock was issued.On average, Wall Street analysts predict. that Bluebird Bio's share price could reach $7.64 by Nov 8, 2024. The average Bluebird Bio stock price prediction forecasts a potential upside of 96.45% from the current BLUE share price of $3.89.Shares of Bluebird Bio ( BLUE -0.78%) were crashing 23.3% lower as of 12:18 p.m. EDT on Monday. The big decline came after the company announced two negative developments in its second-quarter ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...In the past week, BLUE stock has gone up by 13.41%, with a monthly gain of 42.79% and a quarterly surge of 17.39%. The volatility ratio for the week is 8.08%, and the volatility levels for the last 30 days are 9.74% for Bluebird bio Inc . The simple moving average for the past 20 […]Earnings for bluebird bio are expected to decrease in the coming year, from ($1.81) to ($1.84) per share. bluebird bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates. Read More.As for liquidity, bluebird bio reported ~$227M in cash, cash equivalents, marketable securities, and restricted cash as of 2022 year-end and indicated a cash runway until Q4 2024, including ~$45M ...Many gene-editing stocks have taken a hit in the past year, but analysts at Strategic Market Research still expect the genome-editing market to grow 17.3% annually and reach $21.3 billion by 2030.On Tuesday morning, gene therapy specialist bluebird bio ( BLUE 2.64%) announced the temporary suspension of two of its clinical trials for LentiGlobin, an experimental gene therapy for sickle ...Bluebird (BLUE) delivered earnings and revenue surprises of 138.89% and 89.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?As for liquidity, bluebird bio reported ~$227M in cash, cash equivalents, marketable securities, and restricted cash as of 2022 year-end and indicated a cash runway until Q4 2024, including ~$45M ...Aug 28, 2023 · Bluebird Bio (BLUE 11.52%), a leader in gene therapy, could be a great pick for growth investors.This company has two gene therapies that the U.S. Food and Drug Administration (FDA) has approved ... Item 1.01. Entry into a Material Definitive Agreement. On January 18, 2023, bluebird bio, Inc. entered into an underwriting agreement with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price [email protected]. Investor Contacts. Courtney O’Leary. Investor Relations (978) 621-7347. [email protected]. stock quote stock sub menu. Stock Quote; Stock Chart (Common Stock) Exchange (US Dollar) Price: Change (%) Volume: Today's Open: Previous Close: Intraday High: Intraday Low:28 thg 4, 2023 ... According to data from Fintel, the short interest for BLUE stock reached 23.81% of its float. As well, its off-exchange short volume ratio hit ...Shares of Bluebird Bio ( BLUE 0.61%) were sinking 10.4% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The decline came after the company ...Feb 24, 2023 · The market expects Bluebird Bio (BLUE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2022. This widely-known consensus ... bluebird bio (BLUE) Stock Gains 25.6% in a Month: Here's How. bluebird bio (BLUE) rises 25.6% in past thirty days on upbeat earnings results and promising progress with its …With the stock down 52% in the last three months, Bluebird Bio (BLUE-1.28%) shareholders are bound to be feeling pretty antsy. Between the company's weak cash position, missed deadline for a drug ...Specifically, the biotech's stock is down by 11% as of 12:56 p.m. ET on Monday. Bluebird's shares are retreating today in response to two key issues: First, the company's 2021 fourth-quarter and ...Bluebird bio Inc’s current trading price is -47.49% away from its 52-week high, while its distance from the 52-week low is 78.77%. The stock’s price range over this period has fluctuated between $2.52 and $8.58. The company, operating within the financial sector, had a trading volume of approximately 2.61 million for the day, which was ...The U.S. Food and Drug Administration on Wednesday approved bluebird bio's gene therapy for patients with a rare disorder requiring regular blood transfusions, and the drugmaker priced it at a ...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Monday. The stock initially surged in premarket trading following the U.S. Food and Drug Administration's accelerated approval of ...Apple Inc. Common Stock. $191.6541 +1.9641 +1.04%. bluebird bio, Inc. Common Stock (BLUE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global ... What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Bluebirdbio stock

bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock. SOMERVILLE, Mass. -- (BUSINESS WIRE)--Jan. 18, 2023-- bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $6.00 per …. Bluebirdbio stock

bluebirdbio stock

- Commercial launch of ZYNTEGLO® (betibeglogene autotemcel) underway; on track for first apheresis in the fourth quarter of 2022 -- Chris Krawtschuk appointed chief financial officer - - Ended quarter with $186M in cash and cash equivalents, marketable securities and restricted cash - SOMERVILLE, Mass.--(BUSINESS WIRE)--Nov. 7, 2022-- bluebird …bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of …bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases.On May 9, bluebird bio will be reporting earnings Q1. Analysts are expecting losses per share of $0.370. Go here to follow bluebird bio stock price in real-time on Markets Insider.Nick Leschly is heading up bluebird bio spinout 2seventy bio as CEO. Eleven months after announcing the split, bluebird bio Inc. has finished the separation of its cancer business. The oncology ...Discover historical prices for BLUE stock on Yahoo Finance. View daily, weekly or monthly format back to when bluebird bio, Inc. stock was issued. Here are three top biotech stocks with major catalysts in December. Editas Medicine ( EDIT ): EDIT will release key clinical data on its sickle cell treatment on Dec. …Bluebird Bio. Market Cap. $425M. Today's Change. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s ...1. bluebird bio. Many biotech stocks soared last year. Not bluebird bio (BLUE-5.14%).Its shares plunged nearly 50%. While that certainly wasn't good for Bluebird shareholders, I think it makes the ...bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...In the past week, BLUE stock has gone up by 13.41%, with a monthly gain of 42.79% and a quarterly surge of 17.39%. The volatility ratio for the week is 8.08%, and the volatility levels for the last 30 days are 9.74% for Bluebird bio Inc . The simple moving average for the past 20 […]Aug 21, 2022 · The most important gene therapy for Bluebird is lovo cel, which has market size of 100k. If that gets approved (which will not happen before 2023), we should see a big spike in share price. They ... The company’s stock opened at $2.4 and closed at $2.2, a drop of 6.4% from the prior closing price of $2.4. This price decline follows a string of positive news for the company, including a strong second quarter performance …Shares of gene therapy company Bluebird Bio ( BLUE 1.92%) were up by a healthy 12.4% on heavy volume as of 11:16 a.m. ET Friday morning. The biotech's stock appears to be getting a boost from both ...What happened. Shares of Bluebird Bio ( BLUE -1.28%) had popped by more than 34.3% at 10:58 ET Friday morning amid a wider rally in the cell and gene therapy segments of the biotech industry. The ...Linda Haig. December 4, 2023. Company. Bluebird bio Inc (NASDAQ:BLUE) has a beta value of 1.00 and has seen 5.06 million shares traded in the last trading session. The company, currently valued at $465.79M, closed the last trade at $4.26 per share which meant it gained $0.44 on the day or 11.52% during that session.Jul 12, 2023 · Curious what investors think of the latest price action? When the Bank of America upgraded its rating for Bluebird, the stock shot up from $3.13 to a high of $3.93, and today it closed at $3.51. Here Are 10 Top Analyst Forecasts For Wednesday. msn.com - November 8 at 9:59 AM. Wedbush Reiterates Neutral Rating for bluebird bio (NASDAQ:BLUE) americanbankingnews.com - November 8 at 4:10 AM. Why Bluebird Bio Stock Soared 7% Higher on Tuesday. finance.yahoo.com - November 7 at 7:10 PM. bluebird (BLUE) Q3 …Investors are ditching this gene therapy stock en masse, for good reason. The share price of bluebird bio ( BLUE -0.91%) is down a staggering 70% over the past year. The company has encountered ...Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Aug 28, 2023 · Bluebird Bio (BLUE 11.52%), a leader in gene therapy, could be a great pick for growth investors.This company has two gene therapies that the U.S. Food and Drug Administration (FDA) has approved ... On average, Wall Street analysts predict. that Bluebird Bio's share price could reach $7.64 by Nov 8, 2024. The average Bluebird Bio stock price prediction forecasts a potential upside of 96.45% from the current BLUE share price of $3.89.On average, Wall Street analysts predict that Bluebird Bio's share price could reach $7.55 by Nov 8, 2024. The average Bluebird Bio stock price prediction ...Bluebird Bio ( BLUE 11.52%) had quite a ride with their stock on Tuesday. Following the gene-editing specialist's release of its latest quarterly results, its shares climbed to a more than 7% gain ...1. Bluebird Bio. Bluebird Bio is a biotech that seeks to develop gene-editing treatments for rare illnesses. Some of the company's efforts came to fruition this year as it finally earned U.S ...Dec 1, 2023 · Who is on bluebird bio's Insider Roster? The list of insiders at bluebird bio includes Alison Cecily Finger, Andrew Obenshain, Anne-Virginie Eggimann, Jason Cole, Jessica Whitten, Joanne Smith-Farrell, Katy Burnett, Nick Leschly, Richard A Colvin, Thomas J Klima, and William D Baird III. Learn more on insiders at BLUE. Apple Inc. Common Stock. $191.6541 +1.9641 +1.04%. bluebird bio, Inc. Common Stock (BLUE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market …7 thg 11, 2023 ... Sarah Alspach of bluebird bio shares valuable guidance for aspiring comms leaders. Her work has earned her a spot as one of Ragan's 2023 Game ...bluebird bio ( NASDAQ: BLUE) is a clinical-stage biotechnology company specializing in developing and commercializing gene therapies for severe genetic and rare diseases. Their business model ...Shares of Bluebird Bio ( BLUE 0.61%) were sinking 10.4% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The decline came after the company ...bluebird bio Inc bluebird bio Inc BLUE Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value …bluebird bio, Inc. Common Stock (BLUE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action – 270 miles per hour. At 2seventy, we think in the language of time. It’s about time we outmaneuver cancer so the people we serve can have MORE…more time building stories with families and friends, experiencing their passions, and living their best lives in …10 thg 3, 2021 ... BLUE Stock Pops On Gene Therapy Analysis ... On the stock market today, BLUE stock jumped 8.1% to 32.48. Bluebird uses an empty virus to deliver ...bluebird bio, Inc. (BLUE) Stock Price, Quote, News & Analysis Black Friday is here! Get Premium + Alpha Picks for ONLY $438 $239 » BLUE bluebird bio, Inc. …Zolmax • 12 days ago. Track Bluebird bio Inc (BLUE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get …Here are three top biotech stocks with major catalysts in December. Editas Medicine ( EDIT ): EDIT will release key clinical data on its sickle cell treatment on Dec. 11. Bluebird Bio ( BLUE ): It ...Dec 4, 2023 · Linda Haig. December 4, 2023. Company. Bluebird bio Inc (NASDAQ:BLUE) has a beta value of 1.00 and has seen 5.06 million shares traded in the last trading session. The company, currently valued at $465.79M, closed the last trade at $4.26 per share which meant it gained $0.44 on the day or 11.52% during that session. Bluebird Bio drives gene therapy stocks higher after FDA review. Jun. 07, 2022 3:59 PM ET bluebird bio, Inc. ... Bluebird bio has posted its best intraday gain since 2014.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Apr 15, 2022 · With its shares down by around 84% in the past year, it's a wonder that investors are still interested in Bluebird Bio ( BLUE -4.44%) at all. It withdrew its beta thalassemia drug, Zynteglo, from ... Our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action – 270 miles per hour. At 2seventy, we think in the language of time. It’s about time we outmaneuver cancer so the people we serve can have MORE…more time building stories with families and friends, experiencing their passions, and living their best lives in …bluebird bio (BLUE) – bluebird bio rallied 7.3% in premarket trading after the Food and Drug Administration approved the company's gene therapy for a rare and lethal brain disease in children.bluebird bio Inc (BLUE) stock is trading at $5.15 as of 3:06 PM on Friday, Mar 3, a rise of $0.20, or 3.94% from the previous closing price of $4.95. The stock has traded between $4.83 and $5.23 so far today. Volume today is light. So far 1,320,042 shares have traded compared to average volume of 3,101,153 shares.The current price bluebird bio (BLUE) is trading at is $3.87, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Popular Channels13 thg 6, 2022 ... Bluebird Bio Stock Set for Largest One-Day Gain in Eight Years ... Bluebird Bio stock was flying high Monday after an advisory committee of the ...bluebird bio Inc. Watch NEW Set a price target alert Open Last Updated: Nov 27, 2023 1:11 p.m. EST Real time quote $ 3.7650 -0.1250 -3.21% Previous Close $3.8900 Advanced Charting Volume: 2.77M... Shares of Bluebird Bio (BLUE-0.78%) were crashing 23.3% lower as of 12:18 p.m. EDT on Monday. The big decline came after the company announced two negative developments in its second-quarter update.Find the latest bluebird bio, Inc. (BLUE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. One particular, let's check out Bluebird. Shares of Bluebird Bio, ticker symbol BLUE, now, you're seeing that move lower by about 11.3%. This is after the Food and Drug Administration approved the ...May 21, 2020 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--May 18, 2020-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $55.00 per share, before underwriting discounts. In addition, bluebird bio has granted the underwriters a 30-day option to ... 18 thg 10, 2019 ... bluebird bio. 994 views · 4 years ago ...more. Alliance for Regenerative ... Bluebird stock pops after FDA approves its gene therapy drug. Yahoo ...Aug 9, 2021 · Shares of Bluebird Bio ( BLUE -0.78%) were crashing 23.3% lower as of 12:18 p.m. EDT on Monday. The big decline came after the company announced two negative developments in its second-quarter ... Apple Inc. Common Stock. $191.6541 +1.9641 +1.04%. bluebird bio, Inc. Common Stock (BLUE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market …Dec 1, 2023 · Who is on bluebird bio's Insider Roster? The list of insiders at bluebird bio includes Alison Cecily Finger, Andrew Obenshain, Anne-Virginie Eggimann, Jason Cole, Jessica Whitten, Joanne Smith-Farrell, Katy Burnett, Nick Leschly, Richard A Colvin, Thomas J Klima, and William D Baird III. Learn more on insiders at BLUE. . Heritage wealth